Navigation Links
Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
Date:3/27/2008

is a winning combination for Modigene and its shareholders," said Avri Havron, CEO of Modigene. "It provides the company with an immediate $2 million in cash and an option to borrow up to another $10 million at very attractive terms. We believe that Modigene's current cash position, our anticipated cash grants from the Israeli government for our human growth hormone program and the option for a $10 million five-year loan provide us with a robust capital structure. We anticipate that these resources will be sufficient to enable us to complete Phase II clinical studies for our two most advanced long-acting protein therapeutics and also provide us with at least three years of operating cash."

The line of credit extended by The Frost Group is initially for a one-year period. If Modigene draws down cash from the line of credit during the one-year period, Modigene will issue to The Frost Group 1.5 million warrants to purchase unregistered common stock of the company. The warrants have a five-year term and a $0.99 exercise price. Although the line of credit is secured, the intellectual property of the company is not part of any lien or security provided to The Frost Group under the line of credit.

"The attractive terms of this financing further demonstrate the strong commitment of the Frost investor group to Modigene," added Mr. Havron. "The structure of the transaction is well-aligned with the interests of all our shareholders. We view the option to borrow up to $10 million at favorable terms an important strategic advantage for a preclinical stage biotechnology company such as Modigene, providing management and our shareholders with the flexibility of significant potential leverage."

For more information on the financing, visit the SEC filings link at our website at http://www.modigeneinc.com.

Modigene's technology is based on a short amino acid sequence, the carboxyl terminal peptide (CT
'/>"/>

SOURCE Modigene Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
2. Modigene to Present at the Roth 2007 New York Investor Conference
3. GeneNews announces 2007 year end results
4. China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results
5. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
7. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
8. Environmental Power Announces Opening of New Corporate Headquarters in Tarrytown, NY
9. Boston Scientific Announces Schedule for ACC 2008
10. China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
11. Medivation Announces Senior Management Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Auckland, New Zealand (PRWEB) May 16, 2013 ... Zealand, was invited to speak to doctors in China about ... across Australia and NZ, this was her first trip to ... , Dr. Hart visited Guangzhou and Fuzhou, home to 12 ... treatments in China is very high at this point in ...
(Date:5/16/2013)... Kitware , a leading ... new Phase II SBIR funding from the U.S. ... an open-source, high performance computing (HPC) simulation and ... researchers to select only the toolkits and applications ... or analysis tasks. , Manufacturers increasingly rely ...
(Date:5/16/2013)... , May 16, 2013 Scientists at the ... Beijing , and the California ... demonstrated a novel therapy for reversing memory decline in ... they find significant cognitive improvement in advanced stage AD ... mechanism for reversing cognitive decline for advanced stage AD ...
(Date:5/16/2013)... YORK , May 16, 2013 ... new market research report is available ... Competitor Analysis: Therapeutic ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The new ...
Breaking Biology Technology:Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8
... 11, 2011 /PRNewswire-Asia/ -- Chinmax Medical Systems Inc., a ... regarding the progress of its lawsuit against Inverness Medical ... According to the Complaint, Inverness Medical Beijing ... the same to Chinmax customers during the period when ...
... SAN DIEGO, April 11, 2011 MabVax Therapeutics, Inc., ... the development of vaccine and antibody based therapies to ... announces that it has received the Phase 2 portion ... the National Cancer Institute (NCI) under the agency,s Streamlined ...
... VIGILAIR Systems, an industry leader in Ultraviolet Germicidal ... and first of its kind hospital study that demonstrated ... with the application of VIGILAIR® air cleaning technology in ... published article , Effect of enhanced ultraviolet germicidal irradiation ...
Cached Biology Technology:Beijing Chaoyang District Court Grants Investigation Letters Against Inverness Medical Beijing, A Subsidiary of Alere Inc. 2MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute 2MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute 3Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections 2
(Date:5/17/2013)... The iCargo project (Intelligent Cargo in Efficient and Sustainable ... thanks to an improvement in the efficiency of intermodal ... assist decision making. It comprises 29 European organisations with ... management. It has a budget totalling 17,000,000 and a ... is working to specify and develop the semantic components ...
(Date:5/17/2013)... LEMONT, Ill. An international team ... internal structure and cell movement inside a living frog ... showcases a new method to advance biological research and ... at Northwestern University and the Karlsruher Institut fr Technologie ... at the U.S. Department of Energy,s Argonne National Laboratory, ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Society for Developmental Biology (SDB) 72nd Annual Meeting ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the SDB 2013 Annual Meeting. , Awards are ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2New X-ray method shows how frog embryos could help thwart disease 2
... scientists, mathematicians, and biologists from around the world have ... genetic ancestry of thousands of individuals in minutes, without ... will be published in the September 2007 edition of ... of its kind that require prior knowledge of an ...
... RESTON, Va. -- Based on the results of a ... basic molecular imaging/nuclear medicine research should be restored to ... largest society for molecular imaging and nuclear medicine professionals. ... National Institutes of Health, the 13-month, $700,000 report was ...
... Veterinary Medicine have demonstrated the potential of a new ... method employs a harmless gene therapy virus that transfers ... then passed naturally on to offspring. Ina Dobrinski, ... Transgenesis and Germ Cell Research at Penn Vet, and ...
Cached Biology News:Computer program traces ancestry using anonymous DNA samples 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 3Penn Veterinary Medicine report new strategy to create genetically-modified animals 2
Purified anti-human CD182 (CXCR2)...
Polyclonal Antibody to AGAP1 / Centaurin, gamma 2...
Mouse monoclonal [b/e4 (9.20)] to Cytochrome P450 2B1 + 2B2 ( Abpromise for all tested applications)....
Goat polyclonal to MLH3 Immunogen: Synthetic peptide: RQSLQQSMPPCEPP (Human) from C Terminus of the protein sequence according to NP_055196....
Biology Products: